Arimidex Clinical Trials This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.

• News
• Research
• Blogs
• Podcasts
• Alerts
• Clinical Trials

A Study of XZP-3287 in Combination With Letrozole/Anastrozole in Patients With Advanced Breast Cancer
Condition:   Advanced Breast Cancer Interventions:   Drug: XZP-3287+ Letrozole/Anastrozole;   Drug: Placebo + Letrozole/Anastrozole Sponsor:   Xuanzhu Biopharmaceutical Co., Ltd. Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 25, 2022 Category: Research Source Type: clinical trials